|1.||Hellerbrand, Claus: 6 articles (01/2015 - 02/2010)|
|2.||Heilmann, Jörg: 6 articles (02/2013 - 10/2009)|
|3.||Gerhäuser, Clarissa: 6 articles (08/2010 - 03/2004)|
|4.||Stevens, Jan F: 5 articles (07/2013 - 05/2004)|
|5.||Dorn, Christoph: 5 articles (02/2013 - 02/2010)|
|6.||Ferrari, Nicoletta: 5 articles (06/2012 - 03/2006)|
|7.||Becker, Hans: 5 articles (09/2005 - 09/2002)|
|8.||Soares, Raquel: 4 articles (11/2013 - 02/2007)|
|9.||Miranda, Cristobal L: 4 articles (07/2013 - 02/2007)|
|10.||Vanhoecke, Barbara: 4 articles (11/2012 - 09/2005)|
|1.||Hepatocellular Carcinoma (Hepatoma)
02/01/2013 - "The aim of this study was to investigate whether xanthohumol may exert chemoprotective activity through the modulation of the nuclear factor erythroid-2-related factor 2 (Nrf2) pathway in immortalized normal THLE-2 hepatocytes and a hepatocellular carcinoma HepG2 cell line. "
11/01/2008 - "In this study, the inhibitory effects of xanthohumol on human hepatocellular carcinoma cell lines were investigated. "
08/15/2007 - "The aim of this study was to reveal the possible anti-genotoxic activity of xanthohumol in metabolically competent human hepatoma HepG2 cells, by use of the comet assay. "
01/01/2015 - "Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma."
11/01/2008 - "It was shown for the first time that xanthohumol from hops effectively inhibits proliferation of human hepatocellular carcinoma cells in vitro."
|2.||Prostatic Neoplasms (Prostate Cancer)
09/01/2010 - "Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells."
02/08/2007 - "The purpose of this study was to investigate the anti-tumorigenic effects of xanthohumol (XN), the major prenylflavonoid in hops, on prostate cancer and benign prostate hyperplasia. "
01/01/2012 - "Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice."
01/01/2012 - "In this study, we have used human hormone-resistant prostate cancer cells, DU145 and PC3, as an in vitro model to assess the efficacy of xanthohumol (XN) against cell growth, motility and invasion. "
04/01/2013 - "α,β-Dihydroxanthohumol (4), obtained through the biotransformation of xanthohumol, showed higher antiproliferative activity against MCF-7 human breast carcinoma cell line than cisplatin, a widely used anticancer therapeutic agent, and a comparably high activity against PC-3 human prostate cancer cell line."
06/15/2012 - "The prenylflavonoid xanthohumol (XN) has shown in vitro and in vivo therapeutic potential against a range of tumors. "
02/29/2012 - "In conclusion, this study demonstrates for the first time that in addition to its originally being considered an agent preventing tumor growth, xanthohumol possesses potent neuroprotective activity. "
10/05/2015 - "Xanthohumol (XN), a prenylflavonoid derived from the hop plant (Humulus lupulus L.) has been found to exhibit a broad spectrum of biological properties, including anti-cancer activity. "
10/05/2015 - "Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro."
06/01/2015 - "Xanthohumol (XN) has emerged as a potential compound that inhibits various types of cancer, but the molecular mechanism underlying the effects of XN remains unclear. "
|4.||Brain Ischemia (Cerebral Ischemia)
02/29/2012 - "Treatment with xanthohumol (0.2 and 0.4 mg/kg; intraperitoneally) 10 min before MCAO dose-dependently attenuated focal cerebral ischemia and improved neurobehavioral deficits in cerebral ischemic rats. "
02/29/2012 - "In the present study, the neuroprotective activity and mechanisms of xanthohumol in rats with middle cerebral artery occlusion (MCAO)-induced cerebral ischemia were examined. "
01/01/2012 - "These results suggest that the protective effects of xanthohumol in this toxic liver injury model involves direct mechanisms related to its ability to block both hepatic inflammation and the activation of hepatic stellate cells, presumable at least in part via decreasing NFκB activity. "
11/22/2013 - "These findings suggest that consumption of xanthohumol (1) by diabetic animals consistently decreases inflammation and oxidative stress, allowing neovascularization control and improving diabetic wound healing. "
11/22/2013 - "Xanthohumol modulates inflammation, oxidative stress, and angiogenesis in type 1 diabetic rat skin wound healing."
01/01/2012 - "Xanthohumol-supplemented beer modulates angiogenesis and inflammation in a skin wound healing model. "
01/01/2012 - "Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis."
|5.||Apolipoproteins E (ApoE)
|6.||2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridine
|2.||Heterologous Transplantation (Xenotransplantation)